Arthritis, Musculoskeletal and Skin Diseases Research in District of Columbia
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $9.2 million to recipients in District of Columbia in 12 grants from fiscal 2021 to 2025, 0.4% of the program's national total. George Washington University (the) received the most, $6.7 million.
- Awarded in District of Columbia$9.2 million
- Awards12
- Share of the program0.4%
- Rank among states34th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 6 | $1.4 million |
| FY 2022 | 7 | $2.5 million |
| FY 2023 | 5 | $2.6 million |
| FY 2024 | 5 | $2.2 million |
| FY 2025 | 3 | $530,695 |
Recipients in District of Columbia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| George Washington University (the) | Colleges and universities | 3 | $6.7 million |
| Children's Research Institute | Nonprofits | 3 | $1.1 million |
| Carnegie Institution of Washington | Nonprofits | 2 | $1.0 million |
| Algometrx Inc | Small businesses | 1 | $201,326 |
| American Society for Bone & Mineral Rese | Nonprofits | 3 | $201,000 |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to District of Columbia?
$9.2 million from fiscal 2021 to 2025, across 12 awards. District of Columbia ranks 34th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in District of Columbia?
The largest recipient is George Washington University (the), with $6.7 million in 3 awards. Next are Children's Research Institute and Carnegie Institution of Washington.
Can organizations in District of Columbia apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in District of Columbia
- National Railroad Passenger Corporation Grants
- Grants to States for Medicaid
- USAID Foreign Assistance for Programs Overseas
- Federal-State Partnership for Intercity Passenger Rail
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Federal Transit Formula Grants
- International Programs to Support Democracy, Human Rights and Labor
- Environmental and Scientific Partnerships and Programs
- International Broadcasting Independent Grantee Organizations
- Highway Planning and Construction